Our Work


Clinical Innovation Adoption


The Oxford Academic Health Science Network’s Clinical Innovation Adoption (CIA) programme helps implement evidence-based innovation in line with NHS needs, improving patient outcomes and reducing NHS costs. It supports changes in practice and improvement, building region-wide capability and capacity and enhancing cost-effectiveness. The programme works closely with NHS leaders in primary and secondary care, commissioners, clinical innovators, industry partners and others in line with both regional and national priorities. Using a tried and trusted ten-step process (see below), the programme has evaluated more than 300 innovations, taking account of potential benefits, impact on patient experience, local priorities and ease of adoption.

Expert input from the team (scroll down to see who they are) covers building the case for change, evaluation, supporting implementation and understanding and overcoming barriers to adoption. As a result, over 30 sustainable and wide-ranging innovations have been implemented across medicines, medical devices, digital and system transformation. Focus areas include reducing stroke risk, heart failure and sleep improvement. The CIA programme also runs an established training programme which has helped 200 innovators.

The CIA programme is overseen by a group chaired by Neil Dardis, Chief Executive of Frimley Health NHS Foundation Trust. This oversight group comprises executives drawn from NHS trusts and universities in the Oxford AHSN region. It is accountable to the Oxford AHSN Board.

Meet The Team


Tracey Marriott

Tracey Marriott, Director of Clinical Innovation Adoption, is an MBA qualified commercial and transformational change professional with over 15 years’ experience within the private and public health sector. She has extensive experience of delivering complex programmes regionally, nationally and across Europe (budget values up to £1.6billion). Tracey manages the Clinical Innovation Adoption team and works closely with the Oxford AHSN Strategic and Industry Partnership team to support the NHS and industry with adoption of innovation.

Hannah Oatley

Hannah has extensive experience of the NHS acute sector, having worked for many years in both operational and strategic management roles at acute trusts. With a background in biochemistry she has a keen interest in how life sciences research can translate to innovations in clinical care.

Ferdinand Manansala

Ferdinand supports the Clinical Innovation Adoption team and has over ten years experience working within the administrative and management setting. He has been working in the NHS since 2010 working within acute, community and mental health settings. Outside of work, Ferdinand is a big fan of basketball.

James Rose

James has been working in the life science sector for ten years in roles in both R&D and market access. James has worked in discovery and development roles and has a PhD in Pharmacy from the University of Nottingham in which he investigated the barriers to adoption and reimbursement of biologic therapies. James has been leading on several projects to support the uptake of innovative drugs, biologics, medical devices and diagnostics in the NHS.

Alison Gowdy

Alison has over 15 years’ experience in the NHS working in senior acute operational roles. She has extensive experience liaising with clinical teams and commissioners, working across organisations to improve patient pathways and in delivering change management programmes.

Matt Williams

Matt is digital health engagement manager working on the Sleepio project. He has over 20 years’ experience working within the mental health, education and voluntary sectors. Matt was previously the Oxford AHSN Early Intervention in Psychosis Clinical Network Manager. In his spare time, he is a Samaritans volunteer and passionate about music and the arts.


Matthew Epton

Matthew has over ten years’ experience working in the NHS in Primary Care Operational Management, Strategic Management, and most recently Primary Care Commissioning roles.  He also has experience in Adult Social Care Business Support and Performance Management. Matthew has an academic research background and has a D.Phil. from Oxford University, Medical Sciences Division.

Helen Norman

Helen previously worked as an Analyst at the OUH, reporting both internally and externally. She specialised in Theatres, Cancer & Hospital Episode Statistics. This was a technical role where she gained extensive experience in relational databases, gaining advanced knowledge of MS Access and SQL Server, as well as acquiring skills in business intelligence packages such as SSRS. Her current role is similar but is a project-based role, assisting others by providing meaningful insights through data analysis. Her role includes interrogating datasets using SQL, producing metrics and charting data.

Samantha Collins

Samantha joined Oxford AHSN in July 2019 to provide programme support to the CIA team. Prior to joining Oxford AHSN she worked in incident reporting, governance and risk management within a NHS Trust.

Seema Gadhia

Seema is the Pharmacy Lead for Clinical Innovation Adoption. Seema has substantial experience of working in community pharmacy; hospital pharmacy; Mental Health Trusts; Primary Care Trusts and Clinical Commissioning Groups. She has also worked as a clinical advisor for Pharmacy Management. Her particular area of expertise is service improvement and has strategically led and delivered a number of change and improvement projects.

Back to Top
Responsive Menu Pro Image Responsive Menu Clicked Image